Innovative WEF-style forums will gather experts from the corporate, neuroscience, and clinical fields to discuss breakthroughs in neurodegeneration research. These sessions aim to advance our understanding and treatment of Alzheimer’s and Parkinson’s diseases by exchanging new insights and addressing current challenges. Each forum features brief introductions by participants, followed by an audience Q&A, with media coverage to share progress in the field.

Session Type

Title

Moderators

🔥 Fireside Debate

MOONSHOTS & MILESTONES: AFTER AMYLOID—WHO WILL OWN THE FUTURE OF NEURODEGENERATION: THERAPIES, BIOMARKERS, OR AI?

Roger Nitsch
Henrietta Nielsen

Forum 1

BIOMARKERS THAT DECIDE: ARE WE READY TO TREAT BEFORE SYMPTOMS?

Melissa Murray
Henrik Zetterberg

Forum 2

THE END OF MONOTHERAPY: COMBINATION STRATEGIES THAT WILL REDEFINE AD & PD

Jeffrey Cummings
Laura Nisenbaum

Forum 3

BEYOND PROTEINS: TARGETING α-SYNUCLEIN, LRRK2 & GBA FROM BIOMARKERS TO DISEASE MODIFICATION.

Jamie Eberling
Ken Mark

Forum 4

AI → IMPACT: CAN DATA-DRIVEN BIOLOGY DELIVER REAL DISEASE-MODIFYING THERAPIES?

Rhoda Au

Forum 5

MICROGLIA IN COMMAND: REPROGRAMMING THE BRAIN–IMMUNE AXIS—BREAKTHROUGHS, TARGETS, AND RISKS

Cynthia Lemere
David Holtzman

Forum 6

PRECISION NEUROLOGY: MATCHING THE RIGHT DRUG TO THE RIGHT PATIENT—FROM BIOMARKERS TO CLINICAL REALITY

Tamara Shiner
Giovanni Frisoni

Forum 6

REWIRING THE FAILING BRAIN: CAN CIRCUIT-BASED THERAPIES RESTORE COGNITION?

Manfred Windisch

VIEW THE FULL PROGRAM